ABIONYX Pharma SA (ABNX.PA)

EUR 1.24

(2.15%)

Operating Expenses Summary of ABIONYX Pharma SA

  • ABIONYX Pharma SA's latest annual operating expenses in 2023 was 4.17 Million EUR , up 27.17% from previous year.
  • ABIONYX Pharma SA's latest quarterly operating expenses in 2024 Q2 was 2.86 Million EUR , down 0.0% from previous quarter.
  • ABIONYX Pharma SA reported a annual operating expenses of 4.74 Million EUR in annual operating expenses 2022, down -23.6% from previous year.
  • ABIONYX Pharma SA reported a annual operating expenses of 6.21 Million EUR in annual operating expenses 2021, up 109.27% from previous year.
  • ABIONYX Pharma SA reported a quarterly operating expenses of 972 Thousand EUR for 2023 Q4, down 0.0% from previous quarter.
  • ABIONYX Pharma SA reported a quarterly operating expenses of 6.03 Million EUR for 2023 FY, up 27.17% from previous quarter.

Annual Operating Expenses Chart of ABIONYX Pharma SA (2023 - 2013)

Historical Annual Operating Expenses of ABIONYX Pharma SA (2023 - 2013)

Year Operating Expenses Operating Expenses Growth
2023 4.17 Million EUR 27.17%
2022 4.74 Million EUR -23.6%
2021 6.21 Million EUR 109.27%
2020 2.96 Million EUR 17.59%
2019 2.52 Million EUR -65.07%
2018 7.22 Million EUR 8.87%
2017 6.63 Million EUR -72.39%
2016 24.03 Million EUR 55.33%
2015 15.47 Million EUR 154.97%
2014 6.06 Million EUR -38.12%
2013 9.8 Million EUR 0.0%

Peer Operating Expenses Comparison of ABIONYX Pharma SA

Name Operating Expenses Operating Expenses Difference
ABIVAX Société Anonyme 127.37 Million EUR 96.721%
Adocia SA 15.62 Million EUR 73.274%
Aelis Farma SA 18.81 Million EUR 77.804%
Biophytis S.A. 14.33 Million EUR 70.857%
Advicenne S.A. 8.21 Million EUR 49.154%
genOway Société anonyme 16.73 Million EUR 75.045%
IntegraGen SA 5.35 Million EUR 21.962%
Medesis Pharma S.A. 1.56 Million EUR -166.974%
Neovacs S.A. 10.34 Million EUR 59.617%
NFL Biosciences SA 4.37 Million EUR 4.512%
Plant Advanced Technologies SA 2.76 Million EUR -51.075%
Quantum Genomics Société Anonyme 1.71 Million EUR -143.136%
Sensorion SA 27.05 Million EUR 84.56%
Theranexus Société Anonyme 3 Million EUR -39.002%
TME Pharma N.V. 5.49 Million EUR 24.013%
Valbiotis SA 9.86 Million EUR 57.676%
TheraVet SA 1.64 Million EUR -154.027%
Valerio Therapeutics Société anonyme 20.32 Million EUR 79.444%
DBV Technologies S.A. 89.4 Million EUR 95.328%
Genfit S.A. 54.8 Million EUR 92.378%
GeNeuro SA 14.35 Million EUR 70.907%
Innate Pharma S.A. 64.57 Million EUR 93.531%
Inventiva S.A. 120.18 Million EUR 96.525%
MaaT Pharma SA 21.59 Million EUR 80.66%
MedinCell S.A. 32.92 Million EUR 87.312%
Nanobiotix S.A. 58.92 Million EUR 92.912%
OSE Immunotherapeutics SA 23.58 Million EUR 82.293%
Poxel S.A. 28.76 Million EUR 85.479%
GenSight Biologics S.A. 32.66 Million EUR 87.211%
Transgene SA 31.23 Million EUR 86.625%
Valneva SE 134.92 Million EUR 96.904%